Literature DB >> 9290607

Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.

R A Chalmers1, C A Stanley, N English, J S Wigglesworth.   

Abstract

A breast-fed female infant died suddenly in the neonatal period at 31 hours of age with profound macrovesicular fatty infiltration of liver, kidney, and muscle on postmortem examination, suggestive of a defect in fatty acid beta-oxidation. Fatty acid and palmitoyl-carnitine oxidation studies and direct enzyme study of cultured skin fibroblasts suggested a deficiency in the oxidation of long-chain fatty acids distal to carnitine palmitoyl-transferase I and before long-chain acyl-coenzyme A dehydrogenases. Deficient activity of carnitine-acylcarnitine translocase was demonstrated with intermediate levels of activity in the infant's parents, consistent with autosomal recessive inheritance. Fatty acid oxidation studies showed deficient oxidation of fatty acids at all chain lengths from C10:0 to C24:0, with partially reduced oxidation of C26:0 fatty acid, indicating the occurrence of a single mitochondrial carnitine-acylcarnitine translocase and demonstrating the requirement in vivo for L-carnitine for mitochondrial transport of all medium- and long-chain fatty acyl moieties. The disorder may have been precipitated in this breast-fed infant by poor initial feeding, fasting stress, and the long-chain triglycerides of human milk. The severity of the disorder prompted prenatal diagnosis, and affected siblings were excluded in two subsequent pregnancies by fatty acid oxidation in cultured chorionic villus cells and amniocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9290607     DOI: 10.1016/s0022-3476(97)70157-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Carnitine-acylcarnitine translocase deficiency is a treatable disease.

Authors:  A I al Aqeel; M S Rashed; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

Review 2.  Genetics and metabolic cardiomyopathies.

Authors:  E C Wicks; P M Elliott
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

3.  Neonatal hepatic steatosis by disruption of the adenosine kinase gene.

Authors:  Detlev Boison; Louis Scheurer; Valérie Zumsteg; Thomas Rülicke; Piotr Litynski; Brian Fowler; Sebastian Brandner; Hanns Mohler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

4.  Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.

Authors:  Chandrashekhar R Gandhi; J Richard Chaillet; Michael A Nalesnik; Sudhir Kumar; Anil Dangi; A Jake Demetris; Robert Ferrell; Tong Wu; Senad Divanovic; Traci Stankeiwicz; Benjamin Shaffer; Donna B Stolz; Stephen A K Harvey; Jiang Wang; Thomas E Starzl
Journal:  Gastroenterology       Date:  2014-10-13       Impact factor: 22.682

Review 5.  Defects in activation and transport of fatty acids.

Authors:  M Brivet; A Boutron; A Slama; C Costa; L Thuillier; F Demaugre; D Rabier; J M Saudubray; J P Bonnefont
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

6.  Medium-chain triglyceride loading test in carnitine-acylcarnitine translocase deficiency: insights on treatment.

Authors:  R Parini; F Invernizzi; F Menni; B Garavaglia; D Melotti; M Rimoldi; S Salera; C Tosetto; F Taroni
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

7.  Carnitine-acylcarnitine translocase deficiency: experience with four cases in Spain and review of the literature.

Authors:  Isidro Vitoria; Elena Martín-Hernández; Luis Peña-Quintana; María Bueno; Pilar Quijada-Fraile; Jaime Dalmau; Sofia Molina-Marrero; Belén Pérez; Begoña Merinero
Journal:  JIMD Rep       Date:  2015-01-23

8.  Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options.

Authors:  Christian Staufner; Martin Lindner; Carlo Dionisi-Vici; Peter Freisinger; Dries Dobbelaere; Claire Douillard; Nawal Makhseed; Beate K Straub; Kimia Kahrizi; Diana Ballhausen; Giancarlo la Marca; Stefan Kölker; Dorothea Haas; Georg F Hoffmann; Sarah C Grünert; Henk J Blom
Journal:  J Inherit Metab Dis       Date:  2015-12-07       Impact factor: 4.982

Review 9.  Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient.

Authors:  D Galron; O S Birk; A Kazanovitz; S W Moses; E Hershkovitz
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

10.  Glucose-free medium exacerbates microvesicular steatosis in cultured skin fibroblasts of genetic defects of fatty acid oxidation. A novel screening test.

Authors:  D L Renaud; V Edwards; G J Wilson; I Tein
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.